← Back

Anhui Guangxin Agrochemical Co Ltd

Anhui Guangxin Agrochemical Co., Ltd. is a Chinese company that researches, develops, produces, and sells pesticide technicals, preparations, and intermediates. Its product portfolio includes fungicides such as carbendazim, thiophanate-methyl, and oxadiazon; herbicides such as diuron, glyphosate, and cyclophosphamide; and insecticides such as thiamethoxam, imidacloprid, and chlorpyrifos. The company also supplies phosgene intermediates and products for medicine and new materials. Founded in 2000 and headquartered in Xuancheng, China, it exports to North America, Europe, Latin America, and Southeast Asia.

Country
Price · split & dividend adjusted
News & notes moving 603599.CG
603599.CG

Guangxin Shares Releases 2026 Interim Report with Net Profit of 357 Million Yuan

Guangxin Shares released its 2026 interim report, with net profit attributable to the parent company of 357 million yuan. The company's total operating revenue was 1.617 billion yuan, down 14.43% from the same period last year. Net cash inflow from operating activities was 270 million yuan, the latest asset-liability ratio was 30.34%, gross margin was 41.23%, and diluted earnings per share was 0.39 yuan.
Jiemian·25dRead more →
603599.CG

Guangxin Agrochemical Holds 10.5 Billion in Cash Yet Borrows 2.4 Billion, Drawing Inquiry; Company Says It's Bill Discounting for Wealth Management

The Shanghai Stock Exchange recently issued an inquiry letter regarding Guangxin Agrochemical's 2025 annual report, focusing on the company's simultaneous high levels of cash-like assets and short-term borrowings. The inquiry letter pointed out that as of the end of 2025, the company's cash-like assets, including monetary funds, trading financial assets, time deposits, and debt investments, totaled approximately 10.537 billion yuan, accounting for 74.59% of total assets, while short-term borrowings during the same period reached as high as 2.404 billion yuan. The exchange required the company to explain the necessity and commercial rationale for maintaining such high borrowings despite ample funds. The company replied that of the 2.404 billion yuan in short-term borrowings, 2.294 billion yuan came from bill discounting, letter of credit discounting, and forfaiting, and 110 million yuan from accounts receivable factoring, rather than traditional bank loans. The company widely uses bills and letters of credit for settlement in internal transactions between parent and subsidiary companies. Considering that investment yields from bank wealth management products are generally higher than bill discounting costs, the company chose to discount some unmatured bills to purchase higher-yield wealth management products in order to earn a stable interest spread. The company emphasized that this practice has business necessity and commercial rationality, and that the underlying assets are all invested in fixed-income products such as urban investment bonds, corporate bonds, and bank deposits, with no funds flowing to related parties.
南方财经网·33dRead more →